Head & Professor,
Department of Pharmacy

| Finding Agency | Project Title | Approved Fund | Duration |
| ICMR | Novel peptide Design, Delivery and treatment for Heart failure | 97 Lakhs | 2025-2028 |
| DST SERB-CRG | Therapeutic potential of endogenous peptides in hypertension | 36 Lakhs | 2021-2024 |
| ICMR | Role of novel endogenous peptides in cardiometabolic disorders | 29 Lakhs | 2021-2024 |
| ICMR | Therapeutic potential of novel MAD2 inhibitors in ovarian cancer | 35 Lakhs | 2022-2025 |
| ISSAR Pharmaceuticals | Pre-Clinical Efficacy Evaluation of synthetic Peptides For the Treatment of Inflammatory Bowel Disease & Sepsis | 29 Lakhs | 2020-2023 |
| Department of Science and Technology (DST) and SERB Under Young Scientist Scheme) | Role of double stranded RNA dependent protein kinase (PKR) in hypertension: Mechanism and prevention | 27 Lakhs | 2015-2018 |
| CSIR | Pharmacological evaluation of novel double stranded RNA dependent protein kinase (PKR) inhibitors for diabetic cardiomyopathy”. | 24 Lakhs | 2015-2018 |
| BITS (Under additional Competitive grant) | Evaluation of novel pharmacological agents targeted at methylglyoxal in diabetic cardiomyopathy | 10 Lakhs | 2015-2017 |
| UGC | Evaluation of pharmacological agents targeted at double stranded RNA dependent protein kinase (PKR) in type 2 diabetes mellitus | 6 Lakhs | 2014-2016 |
| BITS (Research Initiation Grant) | Role of methyglyoxal in diabetic cardiomyopathy | 2 Lakhs | 2014-2016 |
This website uses cookies or similar technologies, to enhance your browsing experience.


